Powder vials
Store at −20 °C (−4 °F) in dry, dark conditions and keep them in the original packaging.

The KLOW example is a 15 unit draw once daily for 10 to 12 weeks, using an 80 mg vial mixed with 3 mL of water. That draw holds 500 mcg each of BPC-157, KPV, and the TB component, plus 2.5 mg of GHK-Cu. The lower example is 12 units, which holds 400 mcg of each plus 2 mg of GHK-Cu.
The amounts in this chart come from online communities. The vial label shows the total peptide in milligrams (mg). The Amount column shows a portion of that total in micrograms (mcg). The syringe mark shows how much liquid corresponds to that amount.
Syringe marks below are based on a 80 mg vial with 3 mL of water added. Change vial size or water in the calculator
| Reported | Amount | Volume | Syringe mark (U-100) | Draws per vial |
|---|
Convert your vial to mcg, because 1 mg is the same as 1,000 mcg.
Divide by your water to see how much is in 1 mL.
Find what one unit holds. A U-100 syringe has 100 units in 1 mL.
Divide your amount by what one unit holds.
These numbers apply to a vial holding 50 mg of GHK-Cu plus 10 mg each of BPC-157, KPV, and the TB component, mixed to about 3 mL. A different formula or water amount changes every number on this page.
0.15 mL, which is 500 mcg each of BPC-157, KPV, and the TB component, plus 2.5 mg of GHK-Cu. Total blend 4 mg. That gives 20 draws per vial on paper.
0.12 mL, which is 400 mcg of each of the three plus 2 mg of GHK-Cu. Total blend 3.2 mg. That gives 25 draws per vial on paper.
Divide the component's milligrams by the water, then multiply by the volume you draw. BPC-157 at 15 units is 10 mg divided by 3 mL times 0.15 mL, which is 0.5 mg, or 500 mcg.
The example is once daily for 10 to 12 weeks. It is a community schedule, not one validated by a controlled human trial of KLOW.
Follow one step at a time. The steps use the water amount from your calculator.
Find the mg printed on your vial and enter it in the calculator. Let a frozen vial reach room temperature first.
Clean the top of the peptide vial and the water vial with an alcohol swab. Let them dry.
Draw bacteriostatic water with a sterile syringe.
Let the water run down the inside wall of the vial. This helps prevent foaming.
Roll the vial until the powder fully dissolves. Do not shake it hard.
Write today's date on the vial and refrigerate it at 2–8 °C (35.6–46.4 °F), away from light.

Pick how many weeks you will run it and how many shots you take each week. The list below shows everything you need.
Store at −20 °C (−4 °F) in dry, dark conditions and keep them in the original packaging.
Keep them refrigerated and away from light. How long a mixed vial lasts depends on the product, so check its stability data.
KLOW puts GHK-Cu, BPC-157, KPV, and TB-500 into one vial. The appeal is obvious: fewer vials and less measuring. The first thing worth looking at is the ratio, because every draw brings all four along together.
The example formula is 50 mg of GHK-Cu plus 10 mg each of BPC-157, KPV, and the TB component, which comes to 80 mg. GHK-Cu is 62.5 percent of the labeled amount and each of the others is 12.5 percent. That lopsided ratio is the thing to understand before you calculate anything.
KPV is the reason people pick KLOW over GLOW. It has been studied in cell and mouse models of intestinal inflammation.
BPC-157 and the TB component are the recovery pair people already run together.
GHK-Cu is the largest component by a wide margin and the one studied for collagen and extracellular matrix.
One vial and one measurement instead of four. The trade is that you cannot adjust any single component.
No controlled human trial of this four-component blend has established a timeline. The quantities in a draw can be calculated exactly, but that is arithmetic, not evidence of an effect.
Pick a topic to see what has been studied.
The interest in KLOW comes from four separate research stories: tendon healing, tissue remodeling, inflammatory signaling, and wound repair. None of them is a study of the finished blend in people.
A 1993 rat wound-chamber study found more collagen and other extracellular matrix material accumulating. It tested GHK-Cu on its own and locally, not as part of a blend.
A 2003 rat Achilles tendon study reported better repair measures after the tendon was cut. Species, route, and study amounts do not transfer to a human blend protocol.
KPV is a three-amino-acid fragment of alpha-MSH. Most of the published work looks at inflammatory response in cell and animal models, particularly in the gut.
TB-500 and full-length thymosin beta-4 get discussed together, but the names are not proof that a vial holds the molecule used in a study. Check the sequence and identity information in the supplier's documentation, because a study of one does not establish the dosing of the other.

Quality varies a lot between sellers. I have been around research peptides for 10 years, and BioEdge is the supplier I send my readers to. Here is why.
The Peptide Report has a business relationship with BioEdge Research Labs. BioEdge sells this product for laboratory research only. BioEdge shipping policy
KLOW is already a blend, so the comparison people want is against the same formula without KPV.
| Stack | Ingredients | Why people stack them |
|---|---|---|
| KLOWOne vial, 80 mg | IngredientsGHK-Cu 50 mg, BPC-157 10 mg, KPV 10 mg, and the TB component 10 mg | Adds inflammatory signalingKPV is what separates KLOW from GLOW. It has been studied in cell and mouse models of intestinal inflammation, which is why people interested in gut inflammation look at this one. |
| GLOWOne vial, 70 mg | IngredientsThe same formula without KPV | The same three, 10 mg lighterAt 15 units both blends hold 500 mcg of BPC-157, 500 mcg of the TB component, and 2.5 mg of GHK-Cu. KLOW's total per draw is 4 mg against GLOW's 3.5 mg, and the difference is the KPV. That is arithmetic, not evidence that one blend works better. See the GLOW dosage guide. |
Pick a tool and try it. Each one uses the numbers from your calculator.
Use the same four steps. Once you can solve these, you can work out the units for any vial you ever pick up.
Your score: 0 correct.
Each line on the syringe is a unit of liquid. A unit measures volume, so the amount of peptide in it depends on your mix.
Tap the syringe or move the slider. The numbers use the vial you entered above. Read the line at the top edge of the plunger.
More water makes the mix weaker, so the same amount takes up more units. The amount of peptide in the vial stays the same.
A draw under 5 units is harder to read accurately. Tap a row to use that water amount.
The example is a 15 unit draw once daily for 10 to 12 weeks, from an 80 mg vial mixed with 3 mL of water. That holds 500 mcg each of BPC-157, KPV, and the TB component, plus 2.5 mg of GHK-Cu. The lower example is 12 units.
0.15 mL holding 500 mcg of BPC-157, 500 mcg of KPV, 500 mcg of the TB component, 2.5 mg of GHK-Cu, and 4 mg of blend in total.
This is the question worth settling first. 500 mcg of one ingredient and 500 mcg of the total blend are very different amounts. At 15 units you get 500 mcg of BPC-157 but 4 mg of blend.
3 mL is what these calculations assume. That makes 26.67 mg of blend per mL. Change the water and every number changes.
20 at 15 units, or 25 at 12 units. Those are theoretical. Some solution stays behind in the vial and syringe, so the real number can be lower.
KPV. KLOW adds 10 mg of it to the same 50 mg of GHK-Cu and 10 mg each of BPC-157 and the TB component, so it totals 80 mg instead of 70 mg.
No. All four move together in the same ratio. Going from 15 units to 12 lowers every component at once.
Most charts assume one vial size and one water amount. If your mix is different, every unit number changes, so run your own numbers.
Instant e-Book Download